IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sanofi

Q4 2024 Holdings

Filed 2025-02-14 | 9 holdings | $174.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
MeiraGTx Holdings plc(MGTX)COMG59665102$74.3M12,197,73742.6%
Novavax(NVAX)COM NEW670002401$55.3M6,880,48131.7%
Inhibrx Biosciences, Inc.(INBX)COM45720N103$17.8M1,157,92610.2%
AnaptysBio(ANAB)COM032724106$10.9M821,9176.2%
IGM Biosciences(1K0)COM449585108$8.8M1,438,9755.0%
Eledon(ELDN)COM28617K101$3.4M814,9801.9%
Lava Therapeutics N.V.SHSN51517105$1.8M1,919,4551.0%
Inozyme, IncCOM45790W108$1.2M443,2550.7%
Q32 Bio Inc.(QTTB)COM746964105$839.6K244,0830.5%